Ma'anshan Fengyuan Pharmaceutical

Ma'anshan Fengyuan Pharmaceutical is a Chinese pharmaceutical manufacturer based in Ma'anshan, Anhui Province, and operates as a key subsidiary of Anhui Fengyuan Pharmaceutical (BBCA Pharmaceutical). The company specializes in the large-scale production of intravenous infusions, including large-volume parenterals such as glucose and sodium chloride injections. In addition to basic clinical infusions, the company manufactures small-volume injections and various active pharmaceutical ingredients (APIs). Its facilities are GMP-certified and serve as a major production base for the parent group's generic drug portfolio. The company's products are widely used across China for anti-infective therapy, cardiovascular health, and clinical nutrition.